A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis
Neurology
.
2012 Mar 13;78(11):841.
doi: 10.1212/01.wnl.0000413180.13413.ce.
Authors
L Grimaldi
,
F Barkhof
,
M Beelke
,
J Burton
,
T Holmoy
,
R Hupperts
,
J Killestein
,
P Rieckmann
,
M Schluep
,
J Smolders
;
SOLAR Study Group
Collaborators
SOLAR Study Group
:
Reinhold Vieth
,
Lizette Ghazi
,
Klemens Angstwurm
,
Simone Cursiefen
,
Ana Martins de Silva
,
Irina Elovaara
,
Juha-Pekka Erälinna
,
Markus Färkkilä
,
Jan-Markus Dörr
,
Masoud Falah
,
Jette Frederiksen
,
Steven Frequin
,
Claudio Gobbi
,
Bernd Griewing
,
Katrin Gross-Paju
,
Elisabeth Gulowsen Celius
,
Christina Käding
,
Claudia Kaiser
,
Jolanta Kalnina
,
Christian Kamm
,
Margitta Kampman
,
Keijo Koivisto
,
Samuel Komoly
,
Christian Lampl
,
Dalia Mickeviciene
,
Kjell-Morten Myhr
,
Lina Malciene
,
Michael Linnebank
,
Martin Marziniak
,
Said Masri
,
Stefanie Müller
,
Rui Pedrosa
,
Dieter Pöhlau
,
Nils Richter
,
Thorsten Rosenkranz
,
Csilla Rosa
,
Ma José Sá
,
Vasco Salgado
,
Johnny Samijn
,
Evert Sanders
,
Taneli Sarasoja
,
Okke Sinnige
,
Bjarne Sivertsen
,
Merja Soilu-Hänninen
,
Martin Stangel
,
Egon Stenager
,
Oliver Stich
,
Florien Stögbauer
,
Toomas Toomsoo
,
Sabine Urbanits
,
Lászlo Vécsei
,
Freek Verheul
,
Uwe K Zettl
PMID:
22411961
DOI:
10.1212/01.wnl.0000413180.13413.ce
No abstract available
Publication types
Letter
Comment
MeSH terms
25-Hydroxyvitamin D 2 / therapeutic use*
Female
Humans
Male
Multiple Sclerosis, Relapsing-Remitting / drug therapy*
Vitamins / therapeutic use*
Substances
Vitamins
25-Hydroxyvitamin D 2